400 related articles for article (PubMed ID: 31955305)
1. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative psoas muscle index as a measure of nutritional status in patients with esophageal cancer receiving neoadjuvant therapy.
Nakayama T; Furuya S; Kawaguchi Y; Shoda K; Akaike H; Hosomura N; Amemiya H; Kawaida H; Sudoh M; Kono H; Ichikawa D
Nutrition; 2021 Oct; 90():111232. PubMed ID: 33964490
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the impact of psoas muscle index, a parameter of sarcopenia, in patients with esophageal squamous cell carcinoma receiving neoadjuvant therapy.
Ozawa Y; Nakano T; Taniyama Y; Sakurai T; Onodera Y; Kamiya K; Hikage M; Sato C; Takaya K; Konno T; Unno M; Kamei T
Esophagus; 2019 Oct; 16(4):345-351. PubMed ID: 30980203
[TBL] [Abstract][Full Text] [Related]
4. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
[TBL] [Abstract][Full Text] [Related]
5. A lower psoas muscle volume was associated with a higher rate of recurrence in male clear cell renal cell carcinoma.
Noguchi G; Kawahara T; Kobayashi K; Tsutsumi S; Ohtake S; Osaka K; Umemoto S; Nakaigawa N; Uemura H; Kishida T; Yao M
PLoS One; 2020; 15(1):e0226581. PubMed ID: 31895931
[TBL] [Abstract][Full Text] [Related]
6. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
[TBL] [Abstract][Full Text] [Related]
7. Impact of measurement of skeletal muscle mass on clinical outcomes in patients with esophageal cancer undergoing esophagectomy after neoadjuvant chemotherapy.
Ishida T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Mori M; Doki Y
Surgery; 2019 Dec; 166(6):1041-1047. PubMed ID: 31607486
[TBL] [Abstract][Full Text] [Related]
8. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia.
Pigneur F; Di Palma M; Raynard B; Guibal A; Cohen F; Daidj N; Aziza R; El Hajjam M; Louis G; Goldwasser F; Deluche E
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1613-1620. PubMed ID: 37203274
[TBL] [Abstract][Full Text] [Related]
9. Effect of Postoperative Muscle Loss After Resection of Non-small Cell Lung Cancer on Surgical Outcomes.
Nakamura R; Yoneyama S; Tobita R; Kurihara S; Hatori T; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Satoh H; Inage Y
Anticancer Res; 2022 Jun; 42(6):3159-3168. PubMed ID: 35641288
[TBL] [Abstract][Full Text] [Related]
10. The psoas muscle index as a predictor of long-term survival after cardiac surgery for hemodialysis-dependent patients.
Kurumisawa S; Kawahito K
J Artif Organs; 2019 Sep; 22(3):214-221. PubMed ID: 31134455
[TBL] [Abstract][Full Text] [Related]
11. Impact of skeletal muscle mass on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Uchida Y; Ishii H; Tanaka A; Yonekawa J; Satake A; Makino Y; Suzuki W; Kurobe M; Mizutani K; Mizutani Y; Fujimoto M; Ichimiya H; Teramoto C; Tamenishi A; Okamoto H; Watanabe J; Kanashiro M; Amano T; Matsubara T; Ichimiya S; Murohara T
Cardiovasc Interv Ther; 2021 Oct; 36(4):514-522. PubMed ID: 33128695
[TBL] [Abstract][Full Text] [Related]
12. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Kobayashi A; Iida T; Yagi S; Taura K; Hatano E; Uemoto S
Surgery; 2016 Mar; 159(3):821-33. PubMed ID: 26603849
[TBL] [Abstract][Full Text] [Related]
13. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Masui T; Mizumoto M; Hammad A; Mori A; Takaori K; Uemoto S
Surgery; 2015 Jun; 157(6):1088-98. PubMed ID: 25799468
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
[TBL] [Abstract][Full Text] [Related]
15. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival.
Deng CY; Lin YC; Wu JS; Cheung YC; Fan CW; Yeh KY; McMahon CJ
AJR Am J Roentgenol; 2018 Mar; 210(3):526-532. PubMed ID: 29364725
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
[TBL] [Abstract][Full Text] [Related]
17. Measuring sarcopenia on pre-operative CT in older adults undergoing emergency laparotomy: a comparison of three different calculations.
Simpson G; Manu N; Magee C; Wilson J; Moug S; Vimalachandran D
Int J Colorectal Dis; 2020 Jun; 35(6):1095-1102. PubMed ID: 32215679
[TBL] [Abstract][Full Text] [Related]
18. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
19. Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis.
Ebadi M; Wang CW; Lai JC; Dasarathy S; Kappus MR; Dunn MA; Carey EJ; Montano-Loza AJ;
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1053-1062. PubMed ID: 30269421
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Akazawa A
PLoS One; 2021; 16(9):e0257594. PubMed ID: 34551011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
